Advancesin bioinformatics and genomic data analysis have enabled the identification ofcancer antigens that are generally overlooked during immune surveillance; theseneoantigens have been shown to possess substantial therapeutic potential
RootsAnalysis is pleased to announce the publication of its recent study, titled, “Neoantigen Targeted Therapies Market, 2019-2030.”
Thereport features an extensive study of the current market landscape, offering aninformed opinion on the likely adoption of these therapeutics over the nextdecade. It features an in-depth analysis, highlighting the capabilities ofvarious stakeholders engaged in this domain. In addition to other elements, thestudy includes:
· A detailed assessment of the current marketlandscape of developers engaged in the development of neoantigen targetedtherapies.
· Detailed profiles of developers of neoantigentargeted therapies (shortlisted on the basis of the number of pipelineproducts).
· A detailed publication analysis of close to300 peer-reviewed, scientific articles published during the period 2015-2019(till February), highlighting the research focus within the industry.
· An in-depth analysis of the various patentsthat have been filed / granted related to neoantigens.
· An analysis of the various partnerships pertainingto neoantigen targeting therapies.
· An analysis of the investments made atvarious stages of development in companies that are focused on developingneoantigen targeted therapies.
Adetailed market forecast, featuring analysis of the current and projectedfuture opportunity across key market segments (listed below)
TargetDisease Indication
· Bone and Cartilage Cancer
· Colorectal Cancer
· Head and Neck Cancer
· Renal Carcinoma
· Hepatocellular Carcinoma
· Lung Cancer
· Gynecological Cancer
· Others
Typeof Treatment
· Personalized
· Off-the-shelf
Typeof Immunotherapy
· Dendritic Cell Vaccine
· DNA / RNA-based Vaccine
· Protein / Peptide-based Vaccine
· TIL-based Therapy
Routeof Administration
· Intradermal
· Intravenous
· Subcutaneous
· Others
KeyGeographical Region
· North America (US)
· Europe (UK, Germany, France, Italy, and Spain
· Rest of the World
Transcriptsof interviews held with the following senior level representatives ofstakeholder companies:
· Gabriel Nistor, Chief Scientific Officer,AIVITA Biomedical
· Ella Sorani, Vice President Research andDevelopment, BioLineRx
· Heinz Lubenau, Chief Operating Officer andCo-Founder, VAXIMM
Keycompanies covered in the report
· Bavarian Nordic
· Genocea Biosciences
· Gradalis
· Immunicum
· Immunovative Therapies
· Iovance Biotherapeutics
· Medigene
· Neon Therapeutics
· Precision Biologics
· Vaxon Biotech
Getan Exclusive PDF Sample
https://www.rootsanalysis.com/reports/257/request-sample.html
AboutRoots Analysis
RootsAnalysis is one of the fastest growing marketresearch companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growingbusiness needs, get in touch at info@rootsanalysis.com
ContactInformation
RootsAnalysis Private Limited
GauravChaudhary
+1(415) 800 3415
Gaurav.Chaudhary@rootsanalysis.com
Readour Latest Research
In Silico / Computer-Aided DrugDiscovery Services Market
Antibody Contract Manufacturing Market
Biopharma Contract Manufacturing Market
Cell Therapy Manufacturing Market
